| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 28.271 | 73.379 | 68.116 | 86.215 | 0 | 209.813 |
| Total Income - EUR | - | - | - | - | 29.439 | 79.769 | 68.447 | 86.594 | 0 | 210.061 |
| Total Expenses - EUR | - | - | - | - | 18.838 | 42.161 | 61.947 | 69.388 | 0 | 168.781 |
| Gross Profit/Loss - EUR | - | - | - | - | 10.601 | 37.609 | 6.500 | 17.205 | 0 | 41.280 |
| Net Profit/Loss - EUR | - | - | - | - | 9.718 | 36.882 | 5.897 | 16.444 | 0 | 34.946 |
| Employees | - | - | - | - | 0 | 1 | 2 | 1 | 0 | 4 |
Check the financial reports for the company - Stesta Med World S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 2.179 | 2.207 | 0 | 17.154 |
| Current Assets | - | - | - | - | 15.031 | 49.531 | 57.219 | 96.210 | 0 | 190.979 |
| Inventories | - | - | - | - | 10.412 | 25.167 | 38.604 | 79.991 | 0 | 149.443 |
| Receivables | - | - | - | - | 701 | 1.881 | 4.146 | 9.906 | 0 | 33.673 |
| Cash | - | - | - | - | 3.918 | 22.484 | 14.469 | 6.314 | 0 | 7.862 |
| Shareholders Funds | - | - | - | - | 9.760 | 41.909 | 46.877 | 63.467 | 0 | 146.427 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 0 | 40 |
| Debts | - | - | - | - | 5.271 | 7.623 | 12.522 | 34.950 | 0 | 61.706 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Stesta Med World S.r.l.